“The right implementation of basic principles of Operational Excellence will lead to a significantly higher performance among pharmaceutical manufacturing plants and thus to a higher overall business performance of the company."
This hypothesis was already proven by OPEX benchmarking and a number of our industry projects and is examined more profoundly using a scientific model. The model consists of the elements Total Productive Maintenance (TPM), Total Quality Management (TQM), Just-in-Time (JIT) and the underlying Management System.
Our benchmarking is based on the belief that performance (KPIs) cannot be evaluated without the consideration of the specific site environment, the structural factors, the management system or specific site roles. Consequently, our analysis sets the focus on the link between the performance scores and the enablers leading to this performance.
- What does it need to be a Top Performer in terms of Operational Excellence?
- What has changed compared to the former benchmarkings?
- Which principles of Operational Excellence are currently implemented?
- What is the future role of manufacturing in the pharmaceutical industry?
- What are the implications for pharmaceutical manufacturing?
- How should pharmaceutical manufacturing respond to the changing environment?
Data Security and Privacy
The benchmarking project will be conducted in accordance to the International Benchmarking Code of Conduct which ensures a correct attitude of all participants. The company data will be handled with utmost discretion and if applicable will be made anonymous. Company specific data is not to be used without prior approval of the respective company. The project initiators reserve to themselves to use the project results in summary and blinded for publications.
Cost of Participation
The investment for the participation in the Benchmarking-Study is 2'500 EUR (excl. VAT) per participating site. For more than three sites, please ask for discounts.